GO:1990724 galectin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990724 (galectin complex) is a cellular_component term describing a homodimeric protein complex that binds a range of carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes.
• Galectin complexes are formed by galectin proteins, such as galectin-1, galectin-2, galectin-3, galectin-8, and galectin-9, which can dimerize and interact with glycoconjugates on cell surfaces and in the extracellular matrix.
• Galectin-3, a key member, coordinates lysosomal repair and removal, and its targeting is explored in inflammatory and fibrotic diseases.
• Galectin-9 forms complexes with ERMAP and dectin-2 to promote Kupffer cell phagocytosis and antitumor immunity.
• Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances immunotherapy efficacy, highlighting its therapeutic potential.
• Research on galectin complexes employs CRISPR knockout, knock-in, overexpression, and screening methods to dissect their roles in cancer, inflammation, and immunity.
Description
The galectin complex (GO:1990724) is a cellular component defined as a homodimeric protein complex capable of binding a range of carbohydrates and involved in anti-inflammatory and pro-apoptotic processes. Galectins are a family of beta-galactoside-binding proteins that play diverse roles in cell-cell and cell-matrix interactions, immune regulation, and disease pathogenesis. The complex is formed by homodimerization of galectin subunits, such as galectin-1 or galectin-2, and can also include other galectins like galectin-3, galectin-8, and galectin-9 in higher-order assemblies. Understanding the galectin complex is crucial for researchers studying inflammation, cancer, and immune responses, as these complexes modulate key signaling pathways and cellular processes. This article provides a comprehensive overview of the galectin complex, its components, functions, and research methodologies, based on authoritative QuickGO data and verified PubMed literature.
galectin complex At A Glance
| GO ID | GO:1990724 |
|---|---|
| GO term | galectin complex |
| Ontology | cellular_component |
| Synonym | galectin-1 complex, galectin-2 complex |
| Major function | Carbohydrate binding, anti-inflammatory and pro-apoptotic processes |
| Definition | A homodimeric protein complex that is capable of binding a range of carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes. |
| Related genes | LGALS1, LGALS2, LGALS3, LGALS8, LGALS9 |
| Disease relevance | Cancer, inflammation, fibrosis, immune regulation |
What Is GO:1990724?
According to the Gene Ontology, GO:1990724 (galectin complex) is a homodimeric protein complex that binds a range of carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes. It is synonymous with galectin-1 complex and galectin-2 complex. This definition highlights the carbohydrate-binding ability and the dual roles in inflammation and apoptosis, which are central to its biological functions.
Why Is galectin complex Important in Cell Biology?
The galectin complex is important because it mediates critical biological processes such as immune regulation, inflammation, and apoptosis, and its dysregulation is implicated in various diseases including cancer, fibrosis, and autoimmune disorders. Targeting galectin complexes, particularly galectin-3, has emerged as a promising therapeutic strategy, with studies showing that genetic deletion or pharmacological inhibition can inhibit tumor progression and enhance immunotherapy efficacy. Moreover, galectin-9 complexes with ERMAP and dectin-2 promote antitumor immunity, underscoring their potential in cancer immunotherapy. Thus, understanding the galectin complex is essential for developing novel diagnostics and therapeutics.
• Galectin complexes modulate anti-inflammatory and pro-apoptotic processes, influencing immune cell function and tissue homeostasis.
• Galectin-3, a component of galectin complexes, coordinates lysosomal repair and removal, impacting cellular stress responses.
• Targeting galectin-3 in inflammatory and fibrotic diseases is a growing therapeutic area.
• Galectin-9 complexes with ERMAP and dectin-2 enhance Kupffer cell phagocytosis and antitumor immunity.
• Genetic deletion of galectin-3 inhibits pancreatic cancer progression and boosts immunotherapy efficacy.
• Galectin-3/EGR1 transcriptional complex drives invasiveness in gastric adenocarcinoma, highlighting its role in cancer.
• Galectin-8, a sub-family member, forms complexes with distinct functions in cellular processes.
• Galectin complexes are involved in cell-cell and cell-matrix interactions, affecting migration and adhesion.
• Dysregulated galectin complexes are associated with fibrosis, cancer, and immune disorders.
• CRISPR-based models enable precise dissection of galectin complex functions in disease.
What Happens During galectin complex?
Formation and Dimerization
In simple terms: Galectin proteins pair up to form a functional complex.
Galectin complexes are formed by homodimerization of galectin subunits, such as galectin-1 and galectin-2, which are characterized by a conserved carbohydrate recognition domain (CRD). This dimerization is essential for their carbohydrate-binding activity and biological functions. Galectin-3, which has a unique structure with a CRD and a non-lectin N-terminal domain, can also oligomerize to form higher-order complexes.
Carbohydrate Recognition and Binding
In simple terms: The complex attaches to sugars on cell surfaces or matrix.
The galectin complex binds to beta-galactoside-containing glycoconjugates on cell surfaces and extracellular matrix components through its CRD. This binding can cross-link glycoproteins and glycolipids, triggering signaling cascades that regulate cell adhesion, migration, and apoptosis. For example, galectin-9 binds to ERMAP and dectin-2 to promote phagocytosis.
Anti-inflammatory and Pro-apoptotic Signaling
In simple terms: The complex helps reduce inflammation and can trigger cell death.
Galectin complexes are involved in anti-inflammatory and pro-apoptotic processes. Galectin-1 and galectin-2 can induce apoptosis in activated T cells, contributing to immune tolerance. Galectin-3, however, has context-dependent roles, including promoting lysosomal repair and removal, which can be anti-inflammatory. The balance of these signals influences disease outcomes.
Regulation of Immune Responses
In simple terms: The complex controls immune cell behavior.
Galectin-9 complexes with ERMAP and dectin-2 on Kupffer cells enhance phagocytosis and antitumor immunity. Galectin-3 modulates macrophage function and cytokine secretion, affecting inflammation and fibrosis. These interactions highlight the complex's role in immune surveillance and homeostasis.
Key Genes Involved in GO:1990724 galectin complex
The following genes encode proteins that are components or regulators of the galectin complex, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LGALS1 | Encodes galectin-1, a homodimeric galectin involved in apoptosis and immune regulation | Studied in cancer, autoimmunity, and inflammation |
| LGALS2 | Encodes galectin-2, forms homodimers and modulates inflammation | Associated with inflammatory bowel disease and cancer |
| LGALS3 | Encodes galectin-3, a chimeric galectin with roles in lysosomal repair, fibrosis, and cancer | Target for anti-fibrotic and anti-cancer therapies |
| LGALS8 | Encodes galectin-8, a sub-family member with diverse functions | Implicated in autophagy, immunity, and cancer |
| LGALS9 | Encodes galectin-9, involved in immune regulation and antitumor immunity | Forms complexes with ERMAP and dectin-2 |
| ERMAP | Erythroid membrane-associated protein, interacts with galectin-9 | Promotes Kupffer cell phagocytosis |
| DECTIN-2 | C-type lectin receptor, binds galectin-9 | Enhances antitumor immunity |
| EGR1 | Early growth response 1, forms transcriptional complex with galectin-3 | Drives invasiveness in gastric adenocarcinoma |
| TRIM49 | E3 ubiquitin ligase, regulates galectin-3/EGR1 complex stability | Deficiency stabilizes complex, promoting invasiveness |
| ITGB1 | Integrin beta-1, interacts with galectins | Modulates cell adhesion and signaling |
| CD45 | Protein tyrosine phosphatase, binds galectins | Regulates T cell signaling |
| CD7 | T-cell antigen, interacts with galectin-1 | Induces apoptosis in T cells |
| MUC1 | Mucin 1, binds galectin-3 | Promotes cancer progression |
| VIM | Vimentin, interacts with galectins | Cytoskeletal regulation |
| TP53 | Tumor suppressor, modulated by galectins | Apoptosis regulation |
| BCL2 | Anti-apoptotic protein, regulated by galectins | Apoptosis resistance |
| CASP3 | Caspase-3, effector of apoptosis | Galectin-induced apoptosis |
| NFKB1 | NF-kB subunit, modulated by galectins | Inflammatory signaling |
How Is galectin complex Regulated?
The galectin complex is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with binding partners. For instance, TRIM49 deficiency stabilizes a galectin-3/EGR1 transcriptional complex, driving invasiveness in gastric adenocarcinoma. Galectin-3 activity is modulated by its oligomerization state and cleavage by matrix metalloproteinases. Additionally, galectin-9 binding to ERMAP and dectin-2 is regulated by glycosylation patterns on target cells. In inflammatory and fibrotic diseases, galectin-3 expression is induced by cytokines such as TGF-beta, and its inhibition reduces fibrosis.
galectin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LGALS3 | Pancreatic cancer, fibrosis, inflammation | KO mice, overexpression cell lines |
| LGALS9 | Liver cancer, antitumor immunity | Knock-in mice, KO models |
| LGALS1 | Autoimmunity, cancer | KO mice, point mutation |
| LGALS2 | Inflammatory bowel disease | KO mice, overexpression |
| TRIM49 | Gastric adenocarcinoma | KO cell lines, knock-in |
Galectin Complex in Cancer
Galectin complexes are implicated in cancer progression, metastasis, and immune evasion. Galectin-3/EGR1 transcriptional complex drives invasiveness in gastric adenocarcinoma, and TRIM49 deficiency stabilizes this complex. Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances immunotherapy efficacy. Galectin-9 complexes with ERMAP and dectin-2 promote antitumor immunity in liver cancer. Targeting galectin-3 with pectin or inhibitors shows potential in cancer therapy.
Galectin Complex in Inflammatory and Fibrotic Diseases
Galectin-3 is a key mediator of inflammation and fibrosis. Targeting galectin-3 in inflammatory and fibrotic diseases has emerged as a therapeutic strategy. Galectin-3 coordinates lysosomal repair and removal, and its dysregulation contributes to chronic inflammation. Galectin-1 and galectin-2 also modulate inflammatory responses, with implications for autoimmune diseases.
Galectin Complex in Immune Regulation
Galectin-9 complexes with ERMAP and dectin-2 on Kupffer cells promote phagocytosis and antitumor immunity. Galectin-1 induces apoptosis in activated T cells, contributing to immune tolerance. These functions highlight the complex's role in immune homeostasis and potential for immunotherapy.
From galectin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does galectin-3 deletion inhibit tumor growth? | LGALS3 knockout mouse models |
| Does point mutation in galectin-1 affect T cell apoptosis? | Point mutation knock-in mice |
| Does overexpression of galectin-9 enhance antitumor immunity? | Galectin-9 overexpression cell lines |
| Does TRIM49 deficiency stabilize galectin-3/EGR1 complex? | TRIM49 knockout gastric cancer cells |
| Does galectin-3 inhibition reduce fibrosis? | LGALS3 knockout mice or pharmacological inhibitors |
| Does galectin-8 mutation affect autophagy? | CRISPR knock-in of mutant LGALS8 |
How to Study the galectin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Gene function loss | Identify essential genes for galectin complex |
| Co-immunoprecipitation | Protein-protein interactions | Map galectin complex components |
| Mass spectrometry | Protein identification and modifications | Characterize galectin complexes |
| Flow cytometry | Apoptosis and immune cell function | Measure galectin-induced apoptosis |
| Fluorescence microscopy | Localization and dynamics | Visualize galectin complexes |
| Phagocytosis assay | Immune cell phagocytosis | Assess galectin-9/ERMAP/dectin-2 function |
| Western blot | Protein expression and cleavage | Detect galectin-3 cleavage |
| qPCR | Gene expression | Measure galectin mRNA levels |
CRISPR Knockout Screening
CRISPR knockout screens can identify genes that regulate galectin complex function. For example, knockout of LGALS3 in pancreatic cancer cells reduces tumor progression and enhances immunotherapy response. Similarly, TRIM49 knockout stabilizes galectin-3/EGR1 complex, increasing invasiveness.
Proteomic and Interaction Studies
Proteomics and co-immunoprecipitation can map galectin complex components and interactions. Galectin-9 complexes with ERMAP and dectin-2 were identified using biochemical assays. Mass spectrometry can reveal post-translational modifications and binding partners.
Imaging and Localization
Fluorescence microscopy and live-cell imaging can visualize galectin complex formation and localization. Galectin-3 recruitment to damaged lysosomes can be tracked using tagged proteins. This helps understand spatiotemporal dynamics.
Functional Assays
Apoptosis, phagocytosis, and inflammation assays measure galectin complex functions. For instance, T cell apoptosis induced by galectin-1 can be quantified by flow cytometry. Phagocytosis assays with Kupffer cells measure galectin-9/ERMAP/dectin-2 function.
How CRISPR Can Be Used to Study GO:1990724 galectin complex
Knockout
CRISPR knockout of galectin genes, such as LGALS3, has been used to demonstrate its role in pancreatic cancer progression and immunotherapy efficacy. Knockout of TRIM49 stabilizes galectin-3/EGR1 complex, promoting invasiveness. These models are valuable for loss-of-function studies.
Point Mutation
Point mutations in galectin genes can dissect specific residues required for carbohydrate binding or dimerization. For example, mutating the CRD of galectin-1 abolishes its apoptotic function. Such models help understand structure-function relationships.
Knock-in
Knock-in of tagged galectins (e.g., GFP or HA) allows visualization and pull-down of complexes. Knock-in of mutant galectin-9 can test its interaction with ERMAP and dectin-2. This approach is useful for tracking endogenous complexes.
Overexpression
Overexpression of galectins, such as galectin-9, can enhance antitumor immunity in cell models. Overexpression of galectin-3 in cancer cells promotes proliferation and invasion. These models are used for gain-of-function studies.
How EDITGENE Supports galectin complex Research
Researchers studying galectin complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, carbohydrate binding, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for galectin complex research.
Frequently Asked Questions About galectin complex
What is the galectin complex?
The galectin complex (GO:1990724) is a homodimeric protein complex that binds carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes.
What genes are involved in the galectin complex?
Key genes include LGALS1, LGALS2, LGALS3, LGALS8, and LGALS9, which encode galectin proteins that form the complex.
What is the function of galectin-3 in the galectin complex?
Galectin-3 coordinates lysosomal repair and removal and is involved in inflammation, fibrosis, and cancer progression.
How is the galectin complex regulated?
It is regulated by gene expression, post-translational modifications, and interactions with partners like TRIM49 and EGR1.
What diseases are associated with the galectin complex?
It is associated with cancer, inflammatory and fibrotic diseases, and immune disorders.
How can CRISPR be used to study the galectin complex?
CRISPR knockout, knock-in, point mutation, and overexpression models can dissect gene functions in the complex.
What is the role of galectin-9 in immunity?
Galectin-9 forms complexes with ERMAP and dectin-2 to promote Kupffer cell phagocytosis and antitumor immunity.
What are the synonyms for GO:1990724?
The synonyms are galectin-1 complex and galectin-2 complex.
What is the ontology of GO:1990724?
It is a cellular_component term.
How does galectin-3 contribute to pancreatic cancer?
Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances immunotherapy efficacy.
Conclusion
The galectin complex (GO:1990724) is a critical cellular component with diverse roles in carbohydrate binding, immune regulation, and disease. Its components, including galectin-1, -2, -3, -8, and -9, are implicated in cancer, inflammation, and fibrosis, making them attractive therapeutic targets. Advances in CRISPR-based models and screening technologies are accelerating our understanding of galectin complex biology and its potential for clinical translation. EDITGENE's services support researchers in dissecting these pathways with precision.
References
- 1. Qin ZY et al.. 2026. TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex That Drives Invasiveness of Gastric Adenocarcinoma.. Cancer Res 86(2):402-420 PMID: 40997315
- 2. Pedrosa LF et al.. 2022. The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?. Biomolecules 12(2) PMID: 35204790
- 3. Bouffette S et al.. 2023. Targeting galectin-3 in inflammatory and fibrotic diseases.. Trends Pharmacol Sci 44(8):519-531 PMID: 37391294
- 4. Bidon N et al.. 2001. Galectin-8: a complex sub-family of galectins (Review).. Int J Mol Med 8(3):245-50 PMID: 11494049
- 5. Jia J et al.. 2020. Galectin-3 Coordinates a Cellular System for Lysosomal Repair and Removal.. Dev Cell 52(1):69-87.e8 PMID: 31813797
- 6. Li J et al.. 2023. The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity.. Nat Immunol 24(11):1813-1824 PMID: 37813965
- 7. John S et al.. 2016. Galectin-9: From cell biology to complex disease dynamics.. J Biosci 41(3):507-34 PMID: 27581941
- 8. Yang D et al.. 2024. Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy.. Gastroenterology 167(2):298-314 PMID: 38467382
